TrialJournal of the American Society of Nephrology : JASN2023

Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).

Norberto Perico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.